Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VNDA
일자시간출처헤드라인심볼기업
2018/12/1106:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/12/1021:00PR Newswire (US)Vanda Announces Positive Pivotal Study Results for HETLIOZ® (tasimelteon) in Patients with Smith-Magenis SyndromeNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/12/0406:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/12/0320:00PR Newswire (US)Vanda Announces Positive Phase II Study Results for Tradipitant in Patients with GastroparesisNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/11/0907:35PR Newswire (US)Vanda Pharmaceuticals Announces Participation at November 2018 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/11/0807:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/11/0806:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/11/0806:01PR Newswire (US)Vanda Pharmaceuticals Reports Third Quarter 2018 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/11/0122:40PR Newswire (US)Vanda Receives FDA Letter Regarding Corporate WebpageNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/10/2305:30PR Newswire (US)Vanda Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 7, 2018NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/10/1105:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/10/0505:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/09/2705:30PR Newswire (US)Vanda Pharmaceuticals Announces Participation at Oppenheimer and Cantor Fitzgerald Fall 2018 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/09/2607:26PR Newswire (US)Rollins Set to Join S&P 500; Inogen to Join S&P MidCap 400; Vanda Pharmaceuticals and Garrett Motion to Join S&P SmallCap 600NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/09/2106:05PR Newswire (US)Vanda Announces Listing of a New HETLIOZ® Patent in the FDA Orange BookNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/09/1308:00PR Newswire (US)HETLIOZ® (Tasimelteon) Driving Study Demonstrates No Impairment in Next Morning PerformanceNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/09/0505:35PR Newswire (US)Vanda Pharmaceuticals Announces Participation at September 2018 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/1506:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/1506:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/1506:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/1505:45PR Newswire (US)Vanda Wins Denial of Petition For Rehearing on Fanapt®NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/1405:01PR Newswire (US)Vanda Pharmaceuticals Announces the Appointment of General CounselNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/0220:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/0205:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/08/0205:01PR Newswire (US)Vanda Pharmaceuticals Reports Second Quarter 2018 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/07/1805:30PR Newswire (US)Vanda Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 1, 2018NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/1605:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/1605:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/1605:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/1605:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:VNDA